The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.
about
Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspectiveRandomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureusCan mupirocin prevent methicillin-resistant Staphylococcus aureus infections?A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infectionsScreening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluationHigh-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineagesThe role of singlet oxygen and oxygen concentration in photodynamic inactivation of bacteria.Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South AfricaPhotodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells.Decolonization of methicillin-resistant Staphylococcus aureus during routine hospital care: Efficacy and long-term follow-up.Emergence of resistance during mupirocin treatment: is it a problem in clinical practice?Complete nucleotide sequence and comparative analysis of pPR9, a 41.7-kilobase conjugative staphylococcal multiresistance plasmid conferring high-level mupirocin resistance.Amplification of the gene for isoleucyl-tRNA synthetase facilitates adaptation to the fitness cost of mupirocin resistance in Salmonella enterica.Outbreak of mupirocin-resistant staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains.Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection.Development and characterization of a Staphylococcus aureus nasal colonization model in mice.Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infection.LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalentsDevelopment of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference.Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery.Is tea tree oil effective at eradicating MRSA colonization? A review.Mediastinitis in pediatric cardiac surgery: Prevention, diagnosis and treatment.Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics.NVC-422 topical gel for the treatment of impetigo.Characterization of the retrocyclin analogue RC-101 as a preventative of Staphylococcus aureus nasal colonizationIn vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.Evaluation of Staphylococcus aureus Eradication Therapy in Vascular SurgeryAromatic Compound-Dependent Staphylococcus aureus Is Safe in a Nasal Colonization Leukopenic Murine Model.Mupirocin - Are we in danger of losing it?Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients.Current options for the treatment of impetigo in children.Clinical significance of emergence of bacterial antimicrobial resistance in the hospital environment.Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSAProspects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections.Prevalence of High and Low Level Mupirocin Resistance among Staphylococcal Isolates from Skin Infection in a Tertiary Care Hospital.Preventing deep wound infection after coronary artery bypass grafting: a review
P2860
Q22305939-8EABCF68-480D-44E0-AEA5-DEB97479F0E0Q24550651-DB5D52D5-1608-4639-80B9-532372B7F506Q24811884-43C3079E-CF16-4F53-8783-A03713AE6A79Q28474929-039A50E4-E413-412A-96B1-9B84A6011B64Q28744168-CBE5B8E8-1883-4A10-8B18-A9C521CADD19Q30356535-C060D6CF-C827-487C-9DC1-148F9D7791D8Q33281981-97A6E9A5-AFFE-480E-9CB9-4C0B65BF39D3Q33403622-53E2E093-B889-4832-82D4-085A89FFB530Q33722039-B2ACD072-CCE6-4DA0-8959-BC7042127C95Q33779980-3C1E11CF-EF81-41B4-8AED-5B962273925CQ33815610-1AAD1611-D18A-4CED-9E72-8EE3F7D772D2Q33826436-15381209-2AEA-4991-92C6-F8952E73434AQ33853188-2537C44C-ACFF-4111-8C26-738234CA51F8Q33962382-907B18D0-3ED4-4D03-86C1-5FB72720DC1BQ33980808-F82A5BD5-7456-4435-A31E-94C351B31E60Q34001970-46C9FE10-AD17-4D0B-A467-10A1874D7C19Q34041943-A6B56278-0352-4102-B9EA-6251F7DF9317Q34058299-451999E6-2D66-4586-94E7-9888F9C23D51Q34171540-E1A4B4B9-09C4-4599-9660-AE2FCC57C806Q34391293-F8F357DE-3088-47A0-8A6B-427C9A4CCCC0Q34410783-477AA7A6-2BB9-499E-9400-B16133181196Q34427076-52F71E96-84F8-4CB1-8FDF-00D779BEB0FAQ35126159-DFF3E571-3D61-4779-BFC2-0D85BE72BF21Q35178191-237DF82F-1056-4761-BE64-82D271022796Q35363804-86C51A49-2723-4994-ACB6-5F45D4BB355EQ35870415-E6E7F2F6-718B-4823-B8F7-84FE7AC76FF7Q36095019-A527E008-0B0D-4515-A467-61B81AFF3A05Q36104940-A5B49083-5492-4C50-A27C-A8C7B009B6D9Q36167419-909508C5-DFEF-4514-B5DA-757F47772D65Q36170529-C5A63270-56F4-40F6-A36F-F4221CF96B0BQ36170598-E4A721C9-8A81-445E-8C9A-B653DFA6CD0EQ36283726-2F856824-41AE-4D04-A9DE-06503B9CCA77Q36292288-325685CC-FF9D-4CF8-8E7E-E25F315D6C36Q36295497-FDCBBCFF-1EEA-4C89-A31B-9E614A5B19CCQ36298961-BCB2169B-7D95-4A6C-B862-701B66012FAEQ36320180-FAD1E911-E8A4-4542-AAD6-C19D3C540C65Q36351234-32E07974-D5D4-4C4E-B66C-A1E285ABD62DQ36505512-B32BBE91-CFD7-43A8-B986-5A93C04F957BQ36668321-5248FE99-A51C-4F75-B9B8-3DFDF048CCD8Q36831165-DBEBFFE0-BD2A-4AF6-AB36-93DD58DF71AB
P2860
The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The emergence of mupirocin res ...... tibiotic prescribing practice.
@ast
The emergence of mupirocin res ...... tibiotic prescribing practice.
@en
The emergence of mupirocin res ...... tibiotic prescribing practice.
@nl
type
label
The emergence of mupirocin res ...... tibiotic prescribing practice.
@ast
The emergence of mupirocin res ...... tibiotic prescribing practice.
@en
The emergence of mupirocin res ...... tibiotic prescribing practice.
@nl
prefLabel
The emergence of mupirocin res ...... tibiotic prescribing practice.
@ast
The emergence of mupirocin res ...... tibiotic prescribing practice.
@en
The emergence of mupirocin res ...... tibiotic prescribing practice.
@nl
P356
P1476
The emergence of mupirocin res ...... tibiotic prescribing practice.
@en
P2093
Cookson BD
P356
10.1093/JAC/41.1.11
P407
P577
1998-01-01T00:00:00Z